Oncternal Therapeutics logo
Oncternal Therapeutics ONCT
€ 0.51 -24.12%

Quartalsbericht 2024-Q3
hinzugefügt 06.11.2024

report update icon

Oncternal Therapeutics Kennzahlen 2011-2024 | ONCT

Kennzahlen Jährlich Oncternal Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 -0.1 -2.9 -6.3 -1.1 -0.5 -9.0 -4.4 -5.0 -1.3 -2.7 -11.4 -10.1

P/S

34.8 1.6 21.4 32.3 15.8 - - - - - - - 22.9

EPS

-13.4 -16.8 -0.6 -0.8 -3.3 -1.8 -1.8 -1.2 -0.1 -0.5 -0.7 -0.4 -0.6

EV (Enterprise Value)

27.3 M -27.1 M 1.47 M -2 M 25.8 M -2.04 M 267 M 73.9 M 110 M 64.8 M 104 M 270 M 280 M

EBITDA per Share

-14.2 -17.1 -0.64 -0.872 -1.44 -11.7 -12.3 -12.5 -10.9 -25.9 -48 -54.6 -39.8

EV/EBITDA

1.3 0.4 -1.2 0.2 -8.5 -2.7 -3.7 -1.1 -2.3 -5.3 -8.4

PEG

-0.0 -0.0 0.09 -0.13 -0.02 -0.1 0.21 -0.72 -0.07 -0.04 0.05 -0.44 0.04

P/B

0.9 0.0 1.0 1.0 2.7 0.8 7.2 3.9 50.6 2.8 10.6 6.5 4.7

P/CF

-0.8 -0.1 -3.5 -6.2 -2.3 -0.5 -11.7 -3.7 -4.7 -1.7 -2.6 -8.3 -10.2

ROE %

-131.37 -72.45 -35.56 -15.25 -238.88 -147.13 -79.56 -89.11 -1006.08 -221.05 -394.15 -56.76 -46.32

ROA %

-107.49 -64.34 -33.48 -14.50 -157.23 -122.66 -65.83 -72.34 -58.39 -77.81 -269.86 -46.86 -42.58

ROCE %

-138.81 -73.72 -35.59 -15.53 -104.28 -149.59 -80.12 -130.38 -1174.88 -169.93 -394.99 -103.01 -46.72

Current Ratio

5.5 8.9 - 20.1 2.8 6.0 5.8 5.3 1.1 1.5 3.3 6.0 12.6

DSO

- - - - - - - - - - - - 24.3

DIO

- - - - - - - - - - - - 55.7

DPO

- - - - - - - - - - - - 421.7

Betriebszyklus

- - - - - - - - - - - - 80.0

Finanzkreislauf

- - - - - - - - - - - - -341.7

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Oncternal Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.86 -2.89 -2.83 - -3.35 -3.05 -3.93 - -0.21 -0.23 -0.2 - -0.19 -0.16 -0.12 - -0.22 -0.34 -0.31 - -0.32 -3.38 -0.62 -0.23 -0.53 -0.68 -0.62 -0.43 -0.53 -0.4 -0.39 -0.44 -0.49 -0.43 0.15 -0.23 2.48 -3.42 -0.17 -0.13 -0.06 -0.15 -0.14 -0.12 -0.14 -0.2 -0.2 -0.17 0.08 -0.17 -0.18 -0.17 -0.15 -0.21 -0.05

EBITDA per Share

- - - - - - - - -0.21 -0.24 -0.2 - -0.2 -0.16 -0.12 - -0.22 -341 -309 - -323 -3.2 K -638 -0.23 -536 -711 -0.62 -0.44 -0.53 -0.4 -0.39 -0.44 -0.49 -0.43 -0.43 -0.42 -0.42 -0.35 -0.36 -0.05 -0.06 -0.14 -0.13 -0.15 -0.14 -0.2 -0.2 -0.21 -0.19 -0.18 -0.19 -0.19 -0.16 -0.19 -0.04

ROE %

-210.10 -144.23 -109.74 -68.38 -84.61 -74.19 -70.21 -44.45 -54.64 -48.60 -40.23 -23.18 -27.07 -20.77 -18.17 -12.99 -47.17 -77.46 -232.19 -209.84 -191.56 -150.98 16.79 27.11 48.69 20.06 -4.82 -15.46 -89.82 -102.35 -116.04 -89.11 -228.51 1681.78 -867.25 -1006.08 -913.75 -2816.95 -298.88 -221.05 -223.12 -279.09 -337.53 -321.24 -343.70 -249.36 -151.30 -56.76 -49.16 -72.85 -65.94 -46.32 -13.00 -14.85 -3.61

ROA %

-141.74 -110.32 -92.11 -60.20 -74.81 -66.58 -63.32 -40.59 -50.19 -45.19 -37.87 -21.90 -25.60 -19.70 -17.27 -12.35 -34.84 -53.64 -154.05 -138.12 -162.77 -148.92 -54.83 -49.04 -44.45 -54.20 -57.07 -65.83 -73.78 -83.61 -94.46 -72.34 -54.42 82.65 -42.35 -58.39 -77.01 -195.61 -67.51 -77.81 -106.36 -153.89 -214.32 -219.94 -238.48 -172.38 -108.31 -46.86 -41.90 -62.68 -58.36 -42.50 -11.95 -13.65 -3.32

ROCE %

-217.53 -150.72 -115.58 -72.34 -88.87 -77.30 -72.12 -44.82 -55.02 -48.70 -40.26 -23.20 -27.09 -20.79 -18.18 -13.00 -47.58 -78.27 -224.43 -202.12 -183.27 -142.16 17.48 -18.47 3.06 -25.77 -51.19 -15.18 -90.06 -102.59 -116.20 -130.38 -416.36 -696.92 -933.34 -1174.88 -884.99 -597.40 -391.93 -170.22 -225.52 -281.59 -340.22 -408.08 -349.23 -292.12 -196.49 -104.26 -93.90 -82.29 -72.60 -49.95 -15.15 -14.70 -3.39

Current Ratio

2.4 2.9 4.7 5.5 7.0 9.1 - 8.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 51.0 47.5 - 44.1 54.4 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 51.0 47.5 - 44.1 54.4 -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 51.0 47.5 - 44.1 54.4 -

Alle Zahlen in USD-Währung